Clinical Trials Logo

Macula Edema clinical trials

View clinical trials related to Macula Edema.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05122702 Recruiting - Macula Edema Clinical Trials

An Innovative Chinese Herbal Formula for Macular Edema

Start date: July 12, 2022
Phase: Phase 2
Study type: Interventional

Macular edema (ME) is caused by hyperpermeability of retinal vessels and/or decreased efflux of fluid across the retinal pigment epithelium induced by outer/inner blood-retinal barrier dysfunction (BRB). It is most commonly seen following many diseases such as diabetes mellitus (DM), intraocular surgery, uveitis, retinal vein occlusion, and posterior segment inflammatory disease. An estimated 11% of patients with DM develop diabetic macular edema (DME). While the overall prevalence of DME among patients with DM aged 20 to 79 years is approximately 7.5%, the risk increases over time. Currently, there is no cure for ME. Chinese medicine (CM) is widely used to manage ME in China and other East Asian countries. Among them, Shenling Baizhu San (SBS) is one of the most commonly used formulae. In this proposal, a randomized, double-blind, placebo-controlled, multicenter clinical trial will be undertaken to evaluate the efficacy and safety of modified SBS (mSBS) developed by the project team for the treatment of ME. Eligible subjects will be recruited and assigned randomly to receive orally mSBS or placebo twice a day for 12 consecutive weeks, with follow-up for another 4 weeks after stopping the treatment to observe the duration of efficacy.

NCT ID: NCT04847869 Recruiting - Clinical trials for Retinal Vein Occlusion

Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema

NIRVO
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

This pilot study aims to establish that treatment with near infrared light (NIR) reduces cystic macular oedema in patients with a retinal vein occlusion.

NCT ID: NCT04775849 Recruiting - Cataract Clinical Trials

Intraoperative Berger Space Imaging (IBSI)

IBSI
Start date: May 20, 2019
Phase: N/A
Study type: Interventional

The investigational device is an approved femtosecond laser (FSL) device with an integrated imaging system to perform certain steps of the cataract procedure. The FSL will perform anterior capsulotomy and lens fragmentation in individuals suffering from age-related cataract with need of cataract surgery. The laser will be reduced to image the Berger space. If not visible, the space will be enhanced with BSS and Volon A to visualize the BS. Cataract surgery will be performed in subjects who have signed an informed consent form. Macula thickness will be measured with Spectralis OCT on screening date. Postoperative examinations will be implemented in accordance with the approved investigational plan on subjects and includes: visual acuity, slitlamp examination and retinal oct imaging.